Literature DB >> 26280970

Treatment of mallet fracture using a percutaneous fixation technique with an 18-gauge needle.

Eun young Rha, Min cheol Lee, Jung ho Lee, Suk ho Moon, Jong won Rhie, Deuk young Oh.   

Abstract

The purpose of this paper is to introduce a simple and intuitive treatment method using an 18-gauge needle for mallet fractures that involve more than one-third of the articular surface. We performed a retrospective review of 17 patients who underwent closed reduction using an 18-gauge needle with transfixation of Kirschner wire between March 2007 and October 2013. According to the Wehbe and Schneider classification, 15 cases were type IB, 1 was type IIB, and 1 was type IIC. The mean size of bony fragments at the time of injury was 53 percent of the articular surface of the distal phalanx. According to Crawford's criteria, 6 of 17 patients had an excellent result, 9 had a good result and 2 had fair results. Our method of percutaneous reduction using an 18-gauge needle with transfixation of Kirschner wire is minimally invasive and is useful for the fixation of mallet fractures.

Entities:  

Mesh:

Year:  2015        PMID: 26280970

Source DB:  PubMed          Journal:  Acta Orthop Belg        ISSN: 0001-6462            Impact factor:   0.500


  3 in total

1.  The Role of High Frequency Ultrasonography in Diagnosis of Acute Closed Mallet Finger Injury.

Authors:  Tiezheng Wang; Hengtao Qi; Jianbo Teng; Zengtao Wang; Bin Zhao
Journal:  Sci Rep       Date:  2017-09-08       Impact factor: 4.379

2.  Extension block and direct pinning methods for mallet fracture: A comparative study.

Authors:  Hyun Ho Han; Hyun Jun Cho; Seong Yeon Kim; Deuk Young Oh
Journal:  Arch Plast Surg       Date:  2018-07-15

3.  K-wire fixation vs 23-gauge percutaneous hand- crossed hypodermic needle for the treatment of distal phalangeal fractures.

Authors:  Letizia Senesi; Andrea Marchesini; Pier Paolo Pangrazi; Marialuisa De Francesco; Antonio Gigante; Michele Riccio; Francesco De Francesco
Journal:  BMC Musculoskelet Disord       Date:  2020-09-02       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.